Literature DB >> 18660799

Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells?

Robert G Hawley.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18660799      PMCID: PMC2572214          DOI: 10.1038/mt.2008.142

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  14 in total

1.  Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells.

Authors:  Phillip W Hargrove; Steven Kepes; Hideki Hanawa; John C Obenauer; Deiqing Pei; Cheng Cheng; John T Gray; Geoffrey Neale; Derek A Persons
Journal:  Mol Ther       Date:  2008-01-15       Impact factor: 11.454

2.  Generation of pluripotent stem cells from adult mouse liver and stomach cells.

Authors:  Takashi Aoi; Kojiro Yae; Masato Nakagawa; Tomoko Ichisaka; Keisuke Okita; Kazutoshi Takahashi; Tsutomu Chiba; Shinya Yamanaka
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

3.  A combined chemical and genetic approach for the generation of induced pluripotent stem cells.

Authors:  Yan Shi; Jeong Tae Do; Caroline Desponts; Heung Sik Hahm; Hans R Schöler; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

4.  Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

Authors:  Matthias Stadtfeld; Nimet Maherali; David T Breault; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-02-14       Impact factor: 24.633

5.  RTCGD: retroviral tagged cancer gene database.

Authors:  Keiko Akagi; Takeshi Suzuki; Robert M Stephens; Nancy A Jenkins; Neal G Copeland
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

6.  Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential.

Authors:  Ali Ramezani; Teresa S Hawley; Robert G Hawley
Journal:  Stem Cells       Date:  2008-09-11       Impact factor: 6.277

7.  Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.

Authors:  Tobias Brambrink; Ruth Foreman; G Grant Welstead; Christopher J Lengner; Marius Wernig; Heikyung Suh; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

8.  Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.

Authors:  Niels-Bjarne Woods; Arne Muessig; Manfred Schmidt; Johan Flygare; Karin Olsson; Patrick Salmon; Didier Trono; Christof von Kalle; Stefan Karlsson
Journal:  Blood       Date:  2002-10-17       Impact factor: 22.113

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer.

Authors:  Gary P Wang; Alexandrine Garrigue; Angela Ciuffi; Keshet Ronen; Jeremy Leipzig; Charles Berry; Chantal Lagresle-Peyrou; Fatine Benjelloun; Salima Hacein-Bey-Abina; Alain Fischer; Marina Cavazzana-Calvo; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2008-04-14       Impact factor: 16.971

View more
  14 in total

1.  The stem cell "tunnel" effect.

Authors:  Thomas P Zwaka
Journal:  Mol Ther       Date:  2010-12       Impact factor: 11.454

Review 2.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 3.  Induced pluripotent stem cell technology: a decade of progress.

Authors:  Yanhong Shi; Haruhisa Inoue; Joseph C Wu; Shinya Yamanaka
Journal:  Nat Rev Drug Discov       Date:  2016-12-16       Impact factor: 84.694

4.  Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage.

Authors:  Shangtao Cao; Shengyong Yu; Yan Chen; Xiaoshan Wang; Chunhua Zhou; Yuting Liu; Junqi Kuang; He Liu; Dongwei Li; Jing Ye; Yue Qin; Shilong Chu; Linlin Wu; Lin Guo; Yinxiong Li; Xiaodong Shu; Jiekai Chen; Jing Liu; Duanqing Pei
Journal:  J Biol Chem       Date:  2017-09-21       Impact factor: 5.157

5.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

6.  Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.

Authors:  Lynnsey A Zweier-Renn; Teresa S Hawley; Sandra Burkett; Ali Ramezani; Irene Riz; Rima L Adler; Dennis D Hickstein; Robert G Hawley
Journal:  Genes Chromosomes Cancer       Date:  2010-02       Impact factor: 5.006

Review 7.  Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.

Authors:  Ian Y Chen; Elena Matsa; Joseph C Wu
Journal:  Nat Rev Cardiol       Date:  2016-03-24       Impact factor: 32.419

Review 8.  Upping the ante: recent advances in direct reprogramming.

Authors:  Lars U W Müller; George Q Daley; David A Williams
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

9.  No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells.

Authors:  Thomas Winkler; Amy Cantilena; Jean-Yves Métais; Xiuli Xu; Anh-Dao Nguyen; Bhavesh Borate; Jessica E Antosiewicz-Bourget; Tyra G Wolfsberg; James A Thomson; Cynthia E Dunbar
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

10.  Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions.

Authors:  Florencio Varas; Matthias Stadtfeld; Luisa de Andres-Aguayo; Nimet Maherali; Alessandro di Tullio; Lorena Pantano; Cedric Notredame; Konrad Hochedlinger; Thomas Graf
Journal:  Stem Cells       Date:  2009-02       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.